Recognizing Outstanding Contributions to the Canadian Cancer Research Community On November 8, 2022, the CCRA recognized five outstanding leaders in the Canadian cancer research community at their 2021 Canadian Cancer Research Conference. The 2021 Award Recipients are: Barry Stein, President & CEO Colorectal Cancer Canada is the recipient of theCCRA Award (more…)
Developed in collaboration with the Canadian Cancer Society, Statistics Canada and the Public Health Agency of Canada, with data provided by provincial and territorial cancer registries, this publication provides foundational information of the impact of cancer in Canada. For example, it shows a projected 229,200 cancer diagnoses and 84,600 cancer (more…)
The 2021, 5th Cancer Clinical Trials and RWE Conference Registration is Open! The Registration link is: https://tinyurl.com/CTCONF2021 Over the course of the past several years, Colorectal Cancer Canada (CCC) has endeavoured and made significant progress in fostering patient and patient group partnerships among stakeholders who have been advocating for their engagement (more…)
The Person-Centred Virtual Cancer Care Clinical Guidance document is now available. The COVID-19 pandemic has significantly increased the use of virtual care in many areas, such as cancer care. During the first 7 months of the pandemic, virtual cancer care visits (including telephone or video appointments) increased from ~1-2% to (more…)
The Board of Directors of the Justice Emmett Hall Memorial Foundation is seeking nominations for the 2022 Hall Laureate. The Emmett Hall Memorial Lectureship commemorates the father of Canadian Medicare with an annual address at the CAHSPR Conference. Sponsored by the Hall Foundation, the Hall Laureate is awarded each year (more…)
We are happy to announce that CanREValue’s latest publication, Considerations for Developing a Reassessment Process: Report from the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration’s Reassessment and Uptake Working Group, has been accepted for publication in Current Oncology. Download a copy of this paper. Abstract The Canadian (more…)
Deadline to Submit Expression of Interest: October 22, 2021 Deadline for Full Proposal: November 1, 2021 Study Start Date: November 2021 Study Deadline: May 23, 2022 Budget: up to £40,000 (~$67,000 CAD) For full details see attached .pdf The ICBP is commissioning research that will develop an understanding how COVID-19 impacted cancer services and (more…)
Area: Real World Evidence Analytics Duration: one year with possibility of extension Start date: January 1, 2022 Salary: $50,000 plus benefits The Department of Oncology, Cumming School of Medicine at the University of Calgary is accepting applications for a Postdoctoral Scholar in Real-World Evidence Analytics. Click here to download full (more…)
Patient perspectives of Value Frameworks used to Guide Oncology Treatment DecisionsMay 1, 2021 - 12:27 pmUnderstanding British Columbia cancer patients’ experiences with virtual health before and during the COVID-19 pandemicMay 1, 2021 - 11:53 amBenchmarking End of Life Quality Indicators by Tumor Type & Describing models of palliative care across CanadaApril 1, 2021 - 8:56 amEvaluation of the systemic cancer therapy volume-outcome association: a population-based study to inform the optimal provincial organization and delivery of systemic cancer therapyFebruary 1, 2021 - 12:20 pm
Congratulations to the 2021 CCRA Award Winners!November 8, 2021 - 10:48 am
Canadian Cancer Statistics 2021 Now Available!November 3, 2021 - 9:24 am
5th Patient Group Pathway Model to Accessing Cancer Clinical Trials and Real-World Evidence ConferenceNovember 2, 2021 - 11:37 am
Ontario Health – Person-Centred Virtual Cancer Care Clinical Guidance documentNovember 2, 2021 - 10:40 am